Full-service Independent Global CRO
Cyntax Health Projects PVT LTD offers a comprehensive portfolio of clinical, preclinical and analytical services to support innovator and generic drug development programs of our global clients. We are an independent and professionally managed contract research organization offering scientific leadership, global quality management systems and long term financial stability through a continuous investment in our processes, systems, people, infrastructure, technology and a deep commitment to quality. Together, we serve clients in pharmaceutical, herbal and nutraceuticals and medical devices. Cyntax Health Projects has a team of scientific leaders who are experts in a diverse range of therapeutic areas. We have also offer services for developing scoping review, meta-analysis, systematic reviews and clinical trials. We leverage our scientific leadership to establish and maintain the engagement of unique investigator networks for clinical research services.
Reliable Clinical Research Partner to Pharmaceutical Community
The success of a clinical trial is driven by the strategic selection of an authentic CRO. Our experienced team of highly qualified professionals, a comprehensive portfolio of clinical research services to aid diverse requirements and a robust quality management system guided by our quality culture makes us a partner of choice for some of the leading pharmaceutical companies around the world. Our service portfolio includes Clinical Trial Project management, Phase 1 to 4 Clinical Trials, Drug Regulatory Affairs, Medical Writing, Clinical Data Management, Pharmacovigilance and Clinical Operations. We provide services to help pharmaceutical, medical device, biopharmaceutical and nutraceutical/ herbal companies to transform scientific discoveries into new treatments.
Our Broad Range of Specialized Services
Pre Clinical Research and Development
Offering a cutting edge drug discovery and formulation services to support and process R&D,medicinal chemistry, toxicology, analytical development and more.
Early Phase Clinical Development
Developing and managing the early phase clinical trails effectively and safely in patients and healthy volunteers.
Late Phase Clinical Development
Offering services for Phase II-IV clinical trails with feasibility reports, data and site management, regulatory submission and more.
Bio-Pharmaceutics & Data Science
Delivering robust reports and analysis to keep all the projects within budget on track and time.
Large Molecules Development
Solving complex large molecules including vaccines and biosimilar challenges with access to fully integrated and developed services that is delivered with safety, speed, quality and flexibility.
Post Marketing Survelliance
Offering a wide spectrum of cost-effective, flexible, high quality and safety monitoring services that can easily fit into your process.
What Makes Cyntax Special?
Patient Safety at Core of Our Trials
Clinical research industry has come a long way from viewing patients as mere “subjects” to playing an integral part in the success of clinical trials. Subject and Patient safety is of utmost importance for us and we take all measure in terms of infrastructure and resources to ensure the same.
Cyntax Insights
Launch of Community Empowerment and Menstrual Health and Hygiene Management Centre
We are overwhelmed and proud to announce the inauguration of Cyntax Community Empowerment and Menstrual Health and Hygiene Management (MHM) Centre in Rawalpindi. This initiative addresses a critical need for sustainable menstrual health solutions for women and girls in Pakistan.
MoU between Department of Management Sciences, CECOS University Peshawar and Cyntax Health Projects
We are pleased and excited to share the signing of MOU between Department of Management Sciences, CECOS University Peshawar and Cyntax Health Projects marking the beginning of a strategic and promising partnership aimed at strengthening academia-industry linkages and achieving the Sustainable Development Goals through collaborative innovation, research and shared expertise.
MoU Signing Ceremony with University of Wah
We are pleased and excited to share the signing of MoU between University of Wah and Cyntax Health Projects marking the beginning of a promising and strategic partnership aimed at strengthening academia-industry linkages and achieving the Sustainable Development Goals through collaborative innovation, research and shared expertise. The MoU was signed by Dr. Shaukat Ali, Director ORIC, UOW and Prof. Dr. Madeeha Malik, CEO CHP.
Life at Cyntax
Diversity and Inclusion is integral to our mission of advancing human health. We are committed to advancing human health, delivering value for customers, and helping to achieve better outcomes for patients. Collaboration and teamwork provide the foundation for our accomplishments. We strive every day to create and maintain an environment of inclusion where creativity and new ideas thrive – where people of all backgrounds work together, trust and learn from each other, and leverage a wide range of thoughts, experience and skills to make a difference. As an essential element of our inclusive, innovative workplace, we continually seek to train and develop the best employees with a variety of skills and experience.